nonsmallcell lung cancer

Trial links HRT with lung cancer

MENOPAUSE experts say most women taking HRT should not be worried about a post-hoc analysis of the Women's Health Initiative (WHI) trial linking the therapy to an increased risk from lung cancer. Researchers found that women randomised to combined therapy for 5.6 years were more likely to die from lung cancer compared to those on placebo. The increased risk related to only one type of cancer – non-small-cell lung cancer. Overall, in the study of 16,500 women, some 109 in the HRT group developed lung cancer compared with 85 given placebo, a difference that was not ...